These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35369007)

  • 21. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
    Pérez V; Ibernón M; López D; Pastor MC; Navarro M; Navarro-Muñoz M; Bonet J; Romero R
    PLoS One; 2014; 9(1):e87731. PubMed ID: 24498182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
    PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathobiology of focal segmental glomerulosclerosis: new developments.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.
    Ahn W; Bomback AS
    Am J Kidney Dis; 2020 Jun; 75(6):955-964. PubMed ID: 32331832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced glomerular diseases.
    Garnier AS; Laubacher H; Briet M
    Therapie; 2024; 79(2):271-281. PubMed ID: 37973491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of detached podocytes in differentiating between minimal change disease and early focal segmental glomerulosclerosis, can we rely on routine light microscopy?
    Sobh MM; El Kannishy G; Moustafa F; Eid R; Hamdy N; Tharwat S
    J Nephrol; 2022 Dec; 35(9):2313-2324. PubMed ID: 36350562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Kitano Y; Yoshikawa N; Nakamura H
    Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glomerular parietal epithelial expression of CD44 in minimal change nephrotic syndrome and primary focal segmental glomerulosclerosis: A clinico-pathological study.
    Paul EN; Satish S; Kelur KK; Shetty MS
    Indian J Pathol Microbiol; 2023; 66(3):526-532. PubMed ID: 37530333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.
    Deegens JK; Dijkman HB; Borm GF; Steenbergen EJ; van den Berg JG; Weening JJ; Wetzels JF
    Kidney Int; 2008 Dec; 74(12):1568-76. PubMed ID: 18813290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
    Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
    Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the podocytes in urine in the nephrotic syndrome in childhood].
    Spadło A; Wyka K; Kowalewska-Pietrzak M; Bodalski J
    Pol Merkur Lekarski; 2007 Apr; 22(130):254-7. PubMed ID: 17684921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis.
    Hattori M; Horita S; Yoshioka T; Yamaguchi Y; Kawaguchi H; Ito K
    Am J Kidney Dis; 1997 Nov; 30(5):632-8. PubMed ID: 9370177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis.
    Regele HM; Fillipovic E; Langer B; Poczewki H; Kraxberger I; Bittner RE; Kerjaschki D
    J Am Soc Nephrol; 2000 Mar; 11(3):403-412. PubMed ID: 10703664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
    Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal segmental glomerulosclerosis; why does it occur segmentally?
    Nagata M; Kobayashi N; Hara S
    Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.